CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 51 filers reported holding CATALYST BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,874,000 | -5.1% | 1,429,242 | 0.0% | 1.75% | +5.2% |
| Q2 2021 | $6,189,000 | +58.4% | 1,429,242 | +84.4% | 1.66% | +38.1% |
| Q1 2021 | $3,907,000 | -19.8% | 775,274 | +0.4% | 1.20% | -31.0% |
| Q4 2020 | $4,873,000 | +46.7% | 772,314 | 0.0% | 1.74% | +3.6% |
| Q3 2020 | $3,321,000 | -23.1% | 772,314 | +5.0% | 1.68% | -28.1% |
| Q2 2020 | $4,319,000 | +34.3% | 735,841 | 0.0% | 2.34% | -6.4% |
| Q1 2020 | $3,216,000 | -35.8% | 735,841 | 0.0% | 2.50% | -56.0% |
| Q4 2019 | $5,011,000 | +38.7% | 735,841 | 0.0% | 5.69% | +19.4% |
| Q3 2019 | $3,613,000 | +78.3% | 735,841 | +167.6% | 4.77% | +117.3% |
| Q2 2019 | $2,026,000 | +75.4% | 274,936 | +93.0% | 2.19% | +172.9% |
| Q1 2019 | $1,155,000 | +2.8% | 142,451 | 0.0% | 0.80% | +14.7% |
| Q4 2018 | $1,124,000 | – | 142,451 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 202,281 | $2,759,000 | 1.56% |
| ACUTA CAPITAL PARTNERS, LLC | 450,000 | $6,138,000 | 1.16% |
| NEXTHERA CAPITAL LP | 311,175 | $4,244,000 | 0.78% |
| Avoro Capital Advisors LLC | 400,000 | $5,456,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $818,000 | 0.34% |
| B. Riley Wealth Advisors, Inc. | 62,500 | $853,000 | 0.12% |
| Kalos Management, Inc. | 12,100 | $222,000 | 0.10% |
| J. Goldman & Co LP | 124,500 | $1,698,000 | 0.09% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $205,000 | 0.02% |
| DRW Securities, LLC | 12,000 | $164,000 | 0.02% |